TAMPA, Fla.--(BUSINESS WIRE)--Neutra Corp. (OTCQB: NTRR) and joint venture partner Oceanview Health Services Ltd. are preparing to promote and market a new line of cannabis-infused topical products, and the latest data shows that they could soon receive a warm welcome in the nation’s newest medical cannabis state.
The Associated Press reports that infused products and concentrates such as topicals accounted for 11 percent of sales in Illinois’ dispensaries last month. That number is being called a solid start by industry watchers, and likely the beginning of much more to follow. In Washington State, topicals and other infused products accounted for a quarter of total cannabis sales in the third quarter of 2015, according to a report by research firm BDS Analytics.
“The first dispensaries in the state opened last November, but only a very small number of cannabis cultivators in Illinois are currently making infused products,” said NTRR CEO Chris Brown. “We see that as a major opportunity. As patients become better exposed and more familiar with topicals, we’re confident that they will begin to command an even higher share of total sales there.”
Last month, NTRR partner Oceanview Health Services Ltd. revealed the debut products that will comprise its innovative BeKind Topicals line set to hit dispensary shelves this year. The initial lineup will include a pain cream and a topical spray, both infused with different cannabis strains. The new products will be intended for the treatment of arthritis, muscle soreness, nerve pain and other health issues in a discrete and reliable manner. Once they are proven successful, plans call for exploring new opportunities to license the formulas and brand in areas where cannabis use is legal.
In 2016, NTRR plans to deliver many new offerings for cannabis producers and consumers alike as the regulated cannabis industry continues to swell in the United States, Canada and beyond. For more information on the company’s mission, please visit http://neutrainc.com/investors.
About Neutra Corp.
Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. By providing a variety of new technologies designed to ensure safer, more reliable access to cannabis in approved markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals (OTCBB: GWPRF), INSYS Therapeutics, Inc. (NASDAQ: INSY) and ENDEXX Corp. (OTCBB: EDXC), delivering technological advancements in the cultivation and processing of cannabis in approved markets. For investing information and performance data, please visit www.neutrainc.com.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.